Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2906 (LINC02906) is a long intergenic non-coding RNA (lincRNA), typically defined as an autonomously transcribed non-coding RNA longer than 200 nucleotides that does not overlap annotated protein-coding genes[1][3]. LincRNAs are a subset of long non-coding RNAs (lncRNAs) and constitute more than half of the human lncRNA transcriptome[1]. These RNAs can regulate gene expression through various mechanisms, including chromatin remodeling, modulation of transcription, RNA stabilization, and acting in enhancer-like roles in some contexts[1][3]. While some lincRNAs have been found to encode small functional peptides, most lack protein-coding capability and function at the RNA level[1][3]. The specific biological function, disease association, and therapeutic targeting of LINC02906 remain uncharacterized in the current scientific literature, so its clinical or drug-target relevance is unknown at this time[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2906 (LINC02906).